Amgen

IRS: 953540776
AMGN
Amgen

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products.

Founded
1980 (41 years)
CEO
Robert A. Bradway
Investor RelationsSEC
Revenue
24 billion (2020)

Want to see more? Sign up!